FT: Johnson & Johnson Looking to Buy Ollin Biosciences for Up to $3.4 Billion
The Financial Times reports that Johnson & Johnson is looking to buy eye-disease biotech Ollin Biosciences for up to $3.4 billion.
The Financial Times reports that Johnson & Johnson is looking to buy eye-disease biotech Ollin Biosciences for up to $3.4 billion.